These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17220242)

  • 1. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
    Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
    Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR; North KE; Bray MS; Couper DJ; Heiss G; Zeldin DC
    Pharmacogenet Genomics; 2007 May; 17(5):349-58. PubMed ID: 17429317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
    King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
    Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
    Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
    FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
    Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
    Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K; Tauber Z
    Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
    Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
    Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ
    Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and function of CYP2C isoforms in human intestine and liver.
    Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
    Smith HE; Jones JP; Kalhorn TF; Farin FM; Stapleton PL; Davis CL; Perkins JD; Blough DK; Hebert MF; Thummel KE; Totah RA
    Pharmacogenet Genomics; 2008 Nov; 18(11):943-53. PubMed ID: 18769365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation.
    McSorley LC; Daly AK
    Biochem Pharmacol; 2000 Aug; 60(4):517-26. PubMed ID: 10874126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
    Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
    Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.
    Theken KN; Lee CR
    Pharmacogenomics; 2007 Oct; 8(10):1369-83. PubMed ID: 17979511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.
    Wu S; Chen W; Murphy E; Gabel S; Tomer KB; Foley J; Steenbergen C; Falck JR; Moomaw CR; Zeldin DC
    J Biol Chem; 1997 May; 272(19):12551-9. PubMed ID: 9139707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.
    Donnelly MK; Conley YP; Crago EA; Ren D; Sherwood PR; Balzer JR; Poloyac SM
    J Cereb Blood Flow Metab; 2015 Feb; 35(2):267-76. PubMed ID: 25388680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms.
    Enayetallah AE; French RA; Grant DF
    J Mol Histol; 2006 May; 37(3-4):133-41. PubMed ID: 16957870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.